Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal Paclitaxel and Carboplatin in Ovarian Cancer
NCT00181701Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2004
- Primary completion
- May 2006
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of paclitaxel, carboplatin in ovarian carcinoma, primary peritoneal carcinoma (PPC), fallopian tube carcinoma (PFTC), sponsored by Massachusetts General Hospital. Started Oct 2004; status: completed.
02
Drugs
paclitaxelcarboplatin
03
Conditions
ovarian carcinomaprimary peritoneal carcinoma (PPC)fallopian tube carcinoma (PFTC)
Beyond the preview
Go deeper on NCT00181701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00181701.